Schematic illustration of comprehensive and combination RA therapy by Ce-MSCNV nanoparticles. Ce-MSCNVs scavenge the over-produced ROS in an RA knee joint, induce M1 to M2 macrophage polarization for immediate relief of inflammation and symptoms, modulate DCs into tDCs, and finally induce Tregs.
CREDIT: Institute for Basic Science
Ceria nanoparticle-immobilized mesenchymal stem cell nanovesicle hybrid system offers both immediate pain relief and long-term immune tolerance
A team of scientists led by KOO Sagang from the Seoul National University and Center for Nanoparticle Research within the Institue for Basic Science Center (IBS), in collaboration with researchers from Korea Institute of Science and Technology (KIST) and the Seoul National University, developed a new solution for the treatment of rheumatoid arthritis (RA).
RA is a chronic disease that, unfortunately, has no cure. The disease triggers a mix of troublesome symptoms like inflamed joints, harmful cytokines, and immune system imbalances, which work together to create a relentless cycle of worsening symptoms. While targeting some of these factors can provide short-term relief, others remain unresolved, leading to a frustrating cycle of remission and flare-ups.
One of the major hurdles in RA treatment is the inability to restore the immune system to its healthy state. This leaves the body unable to control the continuous production of harmful substances like reactive oxygen species (ROS) and inflammatory cytokines, leading to persistent inflammation and discomfort.
In essence, the ideal treatment for RA should not only provide immediate relief from inflammation and symptoms but also address the root cause by restoring the immune system to its normal, balanced state.
New nanoparticle-based system as a solution
The new platform involves immobilizing ceria nanoparticles (Ce NPs) onto mesenchymal stem cell-derived nanovesicles (MSCNVs). Both of these components can hinder different pathogenic factors, allowing them to work both individually and cooperatively to achieve a comprehensive treatment.
Ce NPs – can scavenge the overproduced ROS in RA-inflicted knee joints. They also induce polarization of M1 macrophages into M2, achieving immediate relief of inflammation and symptoms.
MSCNVs – deliver immunomodulatory cytokines, which turn dendritic cells (DC) into tolerogenic dendritic cells (tDCs). This consequently generates regulatory T cells for long-term immune tolerance.
In short, this approach aims to bridge both innate and adaptive immunity to achieve both short-term pain relief, as well as convert the tissue environment into an immune-tolerant state to prevent the recurrence of symptoms.
Researchers confirmed the efficacy of this approach using a collagen-induced arthritis mouse model. The Ce-MSCNV system was able to comprehensively treat and prevent RA by simultaneously relieving the immediate and restoring T cell immunity. Supporting data suggest that improvement in conditions can be achieved after only a single-dose treatment.
The mice treated with the Ce-MSCNV combination fared far better compared to the ones only treated using the Ce NP or MSCNV group. This clearly demonstrates the synergy between anti-inflammation and immunomodulation and underlines the importance of the combined therapy for effective RA treatment. In addition, Ce-MSCNV administration prior to booster injection markedly reduced the incidence and severity of symptoms, supporting the prophylactic potential of these nanoparticles.
First author KOO Sagang stated, “One of the hardest decisions in intractable disease therapy is determining how long the treatment should be carried on. For RA, it would not be appropriate to stop treatment just because the target marker is stabilized. A safer indicator should be that the innate and adaptive components of the collapsed immune system are normalized to protect the body.”
Koo believes that the strategy adopted by Ce-MSCNVs, where different treatment mechanisms work together, provides a unique advantage in this regard. Furthermore, she predicts that a similar approach would also be applicable to other intractable, inflammatory, and autoimmune diseases for this purpose. The components within the system may also be modified. For example, other catalysts for generating ROS or other cell-derived nanovesicles could be utilized depending on the types of diseases. Overall, this study proves the potential of a hybrid nanoparticle system for the comprehensive treatment of autoimmune disease and modulation of the immune system.
Original Article: New nanoparticles found to be effective for the treatment of rheumatoid arthritis
More from: Seoul National University | Korea Institute of Science and Technology | The Institute for Basic Science
The Latest Updates from Bing News
Go deeper with Bing News on:
Rheumatoid arthritis treatment
- Ask A Doctor: How Can You Tell If You Have Rheumatoid Arthritis?
Expert opinion from Robert H. Shmerling M.D. Senior Faculty Editor, Harvard Health Publishing · 30 years of experience · USA Symptoms of rheumatoid arthritis vary from person to person but typically ...
- Rheumatoid Arthritis Treatment Linked with Lower Dementia Risk
Dementia risk is decreased among patients with rheumatoid arthritis who are treated with biologic disease-modifying antirheumatic ...
- EU researchers are taking fresh approaches to understanding immune-system disorders for more effective treatments
In mid-2015 and early 2016 in Finland, a group of scientists became interested in inspecting doormats. The pursuit, while seemingly unusual, had a serious aim: to determine whether a higher mix of ...
- Anaptys Announces First Quarter 2024 Financial Results and Provides Business Update
Enrollment ongoing for global Phase 2b trial to treat atopic dermatitis (AD) with ANB032, our BTLA agonist; reiterating top-line data anticipated ...
- Aqtual to Present Data on Innovative Approach to Rheumatoid Arthritis Therapy Selection at CCR East 2024
Aqtual, Inc., a precision medicine company using its novel cell-free DNA platform to develop products for chronic diseases and oncology, today announced it is presenting two posters at the Congress of ...
Go deeper with Bing News on:
Ce-MSCNV system
- Zomedica Expands International Reach with CE Certification for VetGuardian(R) System
The CE marking confirms that the VetGuardian system meets all EU health, safety, and environmental protection standards. Importantly, this significant milestone expands the market size for VetGuardian ...
- Continuing to monitor incoming storm system
This system will arrive around 10 this evening and depart before dawn on Friday I'm abrosexual - it took me 30 years to realise 20 random things that are normal in Europe but weird in the U.S.A ...
- OnePlus Nord CE 4 Review: A Balancing Act
Apps open fast and work smoothly. I can tell the difference between a smartphone running OxygenOS and one running another operating system. The OnePlus Nord CE comes with Android 14 and OxygenOS 14.
- The Mesoamerican World System, 200–1200 CE
Between 200 and 1200 CE Central Mexico was the setting for the formation and ... also underscores the critical role that the semi-periphery played in overall world-system configuration and operation ...
- Exploring Education System through EducationinIndia.in
Thank you for choosing to explore the heart of our platform - the About Us page at Educationinindia.in! In an era where information moves at the speed of light, staying informed is not just a ...